More: Hepatitis B: Advances in Screening, Diagnosis, and Clinical Management

Hepatitis B: Advances in Screening, Diagnosis, and Clinical Management CME

Author Information and Disclosures

Release Date: February 25, 2008; Valid for credit through February 25, 2009

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. Treatment of the HBV-Infected Patient: When to Start, When to Stop, and When to Change TherapyEmmet Keeffe, MD, MACP, reviews the indications for treatment and duration of therapy in hepatitis B, as based on current best evidence.Emmet B. Keeffe, MD, MACP (Expert Column, February 2008)
  2. Clinical Evaluation of the HBV-Infected PatientThis review focuses on epidemiology and risk factors, screening recommendations, and interpretation of the serologic tests to accurately diagnose and characterize the status of HBV infection.Anne S. Henkel, MD; Steven L. Flamm, MD (Clinical Focus, February 2008)
  3. Update on the Treatment of Hepatitis BNancy Reau, MD, provides clinical commentary for select feature articles from the literature on issues related to the treatment of hepatitis B.Nancy S. Reau, MD (Literature Review, February 2008)

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Gilead
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the approach to managing the patient with hepatitis B, including when to start therapy, when to stop therapy, and when to alter therapy
  2. Explore the approach to the evaluation of the hepatitis B virus (HBV)-infected patient including interpretation of serologic tests to accurately diagnose and characterize the status of HBV infection
  3. Review recent data in the literature regarding the treatment of hepatitis B, with a focus on issues in drug resistance
Authors and Disclosures

Emmet B. Keeffe, MD, MACP
Disclosure: Emmet B. Keeffe, MD, MACP, has disclosed that he is employed by, and owns stock, stock options, or bonds in, Romark Laboratories. Dr. Keeffe has also disclosed that he has received grants for clinical research from Romark Laboratories and Roche. Dr. Keeffe has also disclosed that he has served as an advisor or consultant to Romark Laboratories, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Idenix, Novartis, and Roche.


Steven L. Flamm, MD
Disclosure: Steven L. Flamm, MD, has disclosed that he has served on the speaker's bureau of Gilead and Novartis.


Anne S. Henkel, MD
Disclosure: Anne S. Henkel, MD, has disclosed no relevant financial relationships.


Nancy S. Reau, MD
Disclosure: Nancy S. Reau, MD, has disclosed that she has received grants for educational activities from Gilead. Dr. Reau has also disclosed that she has served as an advisor or consultant to Bristol-Myers Squibb and Gilead.


Maria L. Gaiso, PhD
Disclosure: Maria Gaiso has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.